Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer
Background The best multimodal approach for resectable locally advanced esophageal
adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is …
adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is …
Unraveling the tumor microenvironment of esophageal squamous cell carcinoma through single-cell sequencing: A comprehensive review
L Qi, J Wang, S Hou, S Liu, Q Zhang, S Zhu… - … et Biophysica Acta (BBA …, 2025 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is a highly heterogeneous and aggressive
malignancy. The progression, invasiveness, and metastatic potential of ESCC are shaped …
malignancy. The progression, invasiveness, and metastatic potential of ESCC are shaped …
Textbook Neoadjuvant Outcome—Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment
Simple Summary This narrative review aims to present the rationale for the implementation
of a novel composite measure, Textbook Neoadjuvant Outcome, among patients with gastric …
of a novel composite measure, Textbook Neoadjuvant Outcome, among patients with gastric …
Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study
G Yang, Y Hong, X Zhang, C Zeng, L Tan… - Cancer Immunology …, 2024 - Springer
Background The time interval between neoadjuvant immunotherapy and surgery is 6 weeks
for esophageal squamous cell carcinoma (ESCC), but whether delayed surgery affects …
for esophageal squamous cell carcinoma (ESCC), but whether delayed surgery affects …
Outcomes of salvage surgery for esophageal carcinoma: a nationwide cohort study from the Dutch upper GI cancer audit
Background Salvage esophagectomy is more complex and associated with higher
postoperative morbidity and mortality than standard resection. This study aimed to …
postoperative morbidity and mortality than standard resection. This study aimed to …
Optimal time-to-surgery recommendations based on primary tumor volume regression for patients with resectable esophageal cancer after neoadjuvant …
J Li, X Zhou, Y Liu, J Zhu, G Wan, Y Wang… - Annals of Surgical …, 2024 - Springer
Background Neoadjuvant chemoradiotherapy (NCRT) has shown promise in improving the
prognosis of individuals with locally advanced esophageal squamous cell carcinoma (LA …
prognosis of individuals with locally advanced esophageal squamous cell carcinoma (LA …
Prolonged time to surgery in patients with residual disease after neoadjuvant chemoradiotherapy for esophageal cancer
HCG Overtoom, BM Eyck, BJ Van Der Wilk… - Annals of …, 2024 - journals.lww.com
Objective: To investigate whether prolonged time to surgery negatively affects survival,
pathological outcome or postoperative complications in patients with histologically proven …
pathological outcome or postoperative complications in patients with histologically proven …
Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer
J Haussmann, W Budach, C Nestle-Krämling… - Radiation …, 2024 - Springer
Background Pathological complete response (pCR) is a well-established prognostic factor in
breast cancer treated with neoadjuvant systemic therapy (naST). The determining factors of …
breast cancer treated with neoadjuvant systemic therapy (naST). The determining factors of …
[HTML][HTML] Impact of Preoperative Time Intervals for Neoadjuvant Chemoradiotherapy on Short-term Postoperative Outcomes of Esophageal Cancer Surgery: A …
J Wang, C de Jongh, Z Wu, EM de Groot… - Annals of …, 2024 - journals.lww.com
Objective: To clarify the impact of the preoperative time intervals on short-term postoperative
and pathologic outcomes in patients with esophageal cancer who underwent neoadjuvant …
and pathologic outcomes in patients with esophageal cancer who underwent neoadjuvant …
Top advances of the year: Gastroesophageal cancer
Top advances of the year: Gastroesophageal cancer - Goodman - 2024 - Cancer - Wiley Online
Library Skip to Article Content Skip to Article Information American Cancer Society Journals …
Library Skip to Article Content Skip to Article Information American Cancer Society Journals …